Tags : King’s College London

Pharma

MSD Signs a License Agreement with King’s College London &

Shots: King’s and Wellcome to receive $340M as development and commercial milestone and royalties on sales. MSD to get a license for conducting lead optimization, preclinical & clinical research The focus of an agreement is to develop therapies for chronic pain and to meet unmet medical needs of patients Professor McNaughton at King’s identifies target […]Read More